Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
Pre-Tax Income
Tandem Diabetes Care Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Pre-Tax Income
-$136.1m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Pre-Tax Income
$1.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Pre-Tax Income
$2.1B
|
CAGR 3-Years
112%
|
CAGR 5-Years
7%
|
CAGR 10-Years
21%
|
|
Stryker Corp
NYSE:SYK
|
Pre-Tax Income
$3.9B
|
CAGR 3-Years
31%
|
CAGR 5-Years
11%
|
CAGR 10-Years
15%
|
|
Abbott Laboratories
NYSE:ABT
|
Pre-Tax Income
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
14%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Pre-Tax Income
$2.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
See Also
What is Tandem Diabetes Care Inc's Pre-Tax Income?
Pre-Tax Income
-136.1m
USD
Based on the financial report for Mar 31, 2024, Tandem Diabetes Care Inc's Pre-Tax Income amounts to -136.1m USD.
What is Tandem Diabetes Care Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-6%
Over the last year, the Pre-Tax Income growth was 32%. The average annual Pre-Tax Income growth rates for Tandem Diabetes Care Inc have been -72% over the past three years , -4% over the past five years , and -6% over the past ten years .